Bal-Öztürk Ayça, Özcan-Bülbül Ece, Gültekin Hazal Ezgi, Cecen Berivan, Demir Ebru, Zarepour Atefeh, Cetinel Sibel, Zarrabi Ali
Department of Stem Cell and Tissue Engineering, Institute of Health Sciences, Istinye University, Istanbul 34396, Türkiye.
Department of Analytical Chemistry, Faculty of Pharmacy, Istinye University, Istanbul 34396, Türkiye.
Pharmaceuticals (Basel). 2023 Mar 16;16(3):445. doi: 10.3390/ph16030445.
Eyes are one of the main critical organs of the body that provide our brain with the most information about the surrounding environment. Disturbance in the activity of this informational organ, resulting from different ocular diseases, could affect the quality of life, so finding appropriate methods for treating ocular disease has attracted lots of attention. This is especially due to the ineffectiveness of the conventional therapeutic method to deliver drugs into the interior parts of the eye, and the also presence of barriers such as tear film, blood-ocular, and blood-retina barriers. Recently, some novel techniques, such as different types of contact lenses, micro and nanoneedles and in situ gels, have been introduced which can overcome the previously mentioned barriers. These novel techniques could enhance the bioavailability of therapeutic components inside the eyes, deliver them to the posterior side of the eyes, release them in a controlled manner, and reduce the side effects of previous methods (such as eye drops). Accordingly, this review paper aims to summarize some of the evidence on the effectiveness of these new techniques for treating ocular disease, their preclinical and clinical progression, current limitations, and future perspectives.
眼睛是人体主要的关键器官之一,它为我们的大脑提供有关周围环境的最多信息。由不同眼部疾病导致的这个信息器官活动紊乱,可能会影响生活质量,因此寻找治疗眼部疾病的合适方法已引起广泛关注。这尤其归因于传统治疗方法在将药物输送到眼内深处方面的无效性,以及泪膜、血眼屏障和血视网膜屏障等屏障的存在。最近,一些新技术被引入,如不同类型的隐形眼镜、微针和纳米针以及原位凝胶,这些技术可以克服上述屏障。这些新技术可以提高治疗成分在眼内的生物利用度,将它们输送到眼后部,以可控方式释放,并减少先前方法(如眼药水)的副作用。因此,这篇综述旨在总结有关这些新技术治疗眼部疾病有效性的一些证据、它们的临床前和临床进展、当前局限性以及未来展望。